Clinical Trials Logo

Clinical Trial Summary

Although one fourth of pregnant women experience at least 1 abortion, yet only 50% of causes are identified. Pregnancy loss can result from viral, bacterial, and other infections. It can reach the fetoplacental units through blood born or local spread. Lower genital tract infections- a potentially preventable infections- was suggested as a cause of spontaneous miscarriage. It was reported in 15 and 66% of early and late miscarriages respectively. These infections are also commonly encountered among apparently healthy looking pregnant women with an overall prevalence of 40-54%. If left untreated it can lead to premature rupture of the membranes, preterm birth, low birth weight, Fetal loss, neonatal ophthalmic and pulmonary damage.


Clinical Trial Description

Abortion was defined by the World Health Organization and the National Center for Health Statistics as pregnancy termination before 20 weeks of gestational age or fetal weight smaller than 500 grams. Abortion is termed early or late if it occurs before 12 weeks or between 12 and 24 weeks of gestation respectively.

Spontaneous abortion prevalence is not exactly known as it varies according to the used method of identification. Wilcox and colleagues in 1988 reported a prevalence of 31 % of pregnancy loss after implantation and over 2/3 of them were clinically silent.

Although one fourth of pregnant women experience at least 1 abortion, yet only 50% of causes are identified. Pregnancy loss can result from viral, bacterial, and other infections. It can reach the fetoplacental units through blood born or local spread.

Lower genital tract infections- a potentially preventable infections- was suggested as a cause of spontaneous miscarriage. It was reported in 15 and 66% of early and late miscarriages respectively. These infections are also commonly encountered among apparently healthy looking pregnant women with an overall prevalence of 40-54%. If left untreated it can lead to premature rupture of the membranes, preterm birth, low birth weight, Fetal loss, neonatal ophthalmic and pulmonary damage.

The suggested mechanisms that genital tract infection can cause abortions are encountered are fetal or placental infection with production of toxic metabolites.

Some organisms like Brucella abortus, Campylobacter fetus, and Toxoplasma gondii can cause abortion in livestock. Their effects in human is unclear. Most infections were not linked to abortions except Chlamydia trachomatis, which was detected in 4% of abortuses compared with < 1 percent of controls.

Chlamydia trachomatis infection incidence was markedly increased in the last years and is responsible for many gynecological conditions as pelvic inflammatory disease and infertility and pregnancy complications as preterm birth and premature rupture of membranes but its relation to early pregnancy loss remains unrecognized.

Baud et al assumed an association between miscarriage and serologic/molecular evidence of C. trachomatis infection. This was evident by the higher prevalence of immunoglobulin G against C. trachomatis in the miscarriage group than in the control group (15.2% vs. 7.3%; p = 0.018) that remained significant after adjustment for age, origin, education, and number of sex partners (odds ratio 2.3, 95% confidence interval 1.1-4.9).

Polymicrobial infection was associated with 2 - 4fold increase in abortion. Data concerning a link between some other infections and increased abortion are conflicting. Oakeshott and coworkers (2002) reported an association between second-, but not first-, trimester miscarriage and bacterial vaginosis with a relative risk of miscarriage before 16 weeks' gestation of 1.2 (0.7 to 1.9).

The present study is designed to determine prevalence of genital tract infections and its relation to occurrence of early miscarriage in women with recent unexplained spontaneous miscarriages ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04152278
Study type Observational
Source Fayoum University Hospital
Contact
Status Completed
Phase
Start date September 1, 2017
Completion date September 30, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01639989 - Doppler Assesment of Blood Flow in the Spiral Arteries N/A
Recruiting NCT06002412 - Quality Control of Ultrasound Images During Early Pregnancy Via AI
Completed NCT03258385 - Vitamin B12 Supplementation to Improve B12 Status and Child Development N/A
Completed NCT03161873 - Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
Active, not recruiting NCT03440866 - Comparison of the Effectiveness of Treatment With Mifepristone and Misoprostol at the Same Time Compared to the Administration of Drugs at a 48-hour Interval for Medical Abortion. N/A
Completed NCT02979834 - When Will I Feel The First Movements of My Baby? N/A
Terminated NCT02847910 - ClinicaI Observation of Induced Abortion With Disposable Tissue Suction Tube N/A
Completed NCT04371991 - Kisspeptin Levels in Early Pregnancy
Active, not recruiting NCT05142020 - Biomarkers for Early Screening of Gestational Diabetes Mellitus
Recruiting NCT04717661 - A Diagnostic Test Study of Characteristic Sound Waves in Radial Artery of Early Pregnant Women
Completed NCT05484869 - Very Advanced Maternal Aged Pregnants and Early Adolescent Pregnant Women
Recruiting NCT04738370 - Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy
Completed NCT06228118 - Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System
Completed NCT06228131 - Detection of hCG in Early Pregnancy Clinical Samples
Active, not recruiting NCT04388605 - Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
Completed NCT00340782 - Influence of Social and Environmental Factors on Women's Reproductive Function in a Maya Community of Guatemala N/A